SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS shares are drawing attention amid a sharp decline and an extended quiet period as traders await the final analysis of the Phase 3 REGAL AML trial and updates on its 80th-event milestone; some expect data around the ASH conference, while others worry the delay signals trouble. The selloff is widely blamed by traders on options expiration, short selling, or manipulation, though those explanations are speculative, and reactions range from buying the dip to frustration over the lack of company updates.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas next-generation Roadster reveal, featuring SpaceX-derived thrusters and airborne maneuvers, is driving attention. Traders are split between praising the engineering and dismissing the car as an impractical, delayed demo with little near-term business impact; some also speculate the showcase signals closer TeslaSpaceX ties or a merger.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Concerns about CoreWeaves debt-funded AI expansion and rising borrowing costs are driving the selloff, with traders also scrutinizing co-founders stock sales. Nvidia CEO Jensen Huangs reassurance and bullish analyst commentary helped spark a sharp rebound, but the community remains divided over whether AI demand and contracted business can offset refinancing and cash-flow risks.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples iPhone Duo preorders reportedly sold out quickly, driving attention as traders debate whether that reflects strong demand or limited initial supply and manufacturing constraints. The news fueled optimism about the launch, while skeptics questioned whether it justifies the rally amid repeated fades near recent highs.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

A Goldman Sachs upgrade to Buy, alongside multiple analyst target increases following Zeta Lives AthenaOS and AI-partnership announcements, is driving attention and renewed momentum. Bulls view the upgrades and product news as validation of Zetas growth prospects, while skeptics warn that the rally may be overextended and could face profit-taking.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

Renewed, unconfirmed takeover speculationabout a West Coast tech company potentially considering an all-stock bid after Stripe-related talks endedis driving attention, with traders frequently guessing Meta could be the buyer. Some see the rumors as a catalyst, while others question their credibility and emphasize PayPals standalone value and its confirmed Meta Muse commerce partnership.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

European regulators reaffirmed their rejection of Omeros Yartemlea application after re-examination, prompting concern about lost access to the European market and debate over the review process. Some traders see the setback as manageable, pointing to U.S. sales growth and possible named-patient access in Europe as the focus shifts to commercial execution.

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is under pressure amid a broader semiconductor and AI-stock selloff and weakness in Korean markets, while traders debate whether the decline reflects doubts about AI spending and memory-cycle durability or concern about Chinese competitor CXMT. Bulls call the pullback oversold and cite HBM demand and low valuations; bears see further downside risk.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Concerns about Pharvaris competing HAE treatment and its potential to pressure Orladeyos growth are weighing on sentiment, alongside reported RBC caution about BioCrysts near-term outlook. Some traders view the selloff as overdone and argue Orladeyo can retain patients while the market awaits further pipeline data.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is drawing attention amid a sharp semiconductor selloff, with traders citing hotter inflation and rate concerns, scrutiny of AI spending and valuations, and weakness in Asian chip markets. The community is split between dip buyers expecting a relief bounce and bears anticipating further declines, while SOXLs 3x leverage intensifies the swings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The weakness appears tied to uncertainty and growing impatience over the prolonged quiet period around SELLASs REGAL Phase 3 trial, including the still-pending event count and topline data. Traders are also pointing to options positioning and expiration as a possible source of added pressure, though no confirmed catalyst is evident.

SLS, IBRX Rise Premarket: Funds Raise Their Bets As J&J Stays ‘On The Lookout’ For Deals

Equity

J&J is open to strategic acquisitions and targets more than $50 billion in oncology sales by 2030.

Dow, S&P 500, Nasdaq Futures Mixed Amid Rising Oil Prices Ahead Of CPI Data: BAC, RIVN, SLS, GME Stocks In Focus

The third-quarter earnings season kicked off this week, with Goldman Sachs, Citigroup, Wells Fargo and JPMorgan Chase reporting their results. 

Why Are Nasdaq Futures Rising Premarket? MU, IREN, SLS, NIO, ASTS, WFF Stocks In Focus

On Stocktwits, retail sentiment toward SPY and QQQ has moderated to ‘bullish’.


SLS Stock Jumps Overnight: Retail Sees Big Pharma Buyout Clues In 'M&A Negotiation Lounge' Booth At ASH

The ASH meeting runs Dec. 12-Dec. 15 in New Orleans. Sellas is listed at Booth 138, and more than 275 exhibitors are expected.

SLS Stock’s 2-Week Rally Loses Steam: Retail Sees ‘Peanut Prices’ As Fresh AML Study Fuels Regal Hopes

A new study of 2,610 AML patients found a median survival of 11.4 months with Venetoclax-based therapy versus 8.2 months with hypomethylating drugs alone.

Nasdaq, S&P 500, Dow Futures Rise Ahead Of Jobs Report: NKE, META, RKLB, MRNA, SLS, TSLA Stocks In Focus

On Stocktwits, retail sentiment toward SPY and QQQ remained ‘bullish’ ahead of jobs data.


SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna’s Rally As MRNA Lands A Nasdaq-100 Spot

Moderna will replace Warner Bros. Discovery in the Nasdaq-100 before markets open on Oct.9.

SLS Stock Snaps 3-Quarter Winning Streak — Retail Traders Speculate On Buyout, Eye Lease Through 2027

Retail investors speculated that Sellas’ office lease through September 2027 provides stability for clinical results and potential deal discussions.

Biotech Lagged The Broader Market In September — Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI’s Slump? 

IOVA surged 77% and IBRX gained 11%, bucking biotech’s decline, while SLS fell 14% and VNDA slipped 7%. 

Stocktwits Pharma Pulse: Lilly, Novo Lead A Busy Week — Here Are The Stocks And Readouts To Watch 

Novo has 44 abstracts at EASD, including CagriSema analyses and Phase 2b Zenagamtide results.

Neutral Sentiment

Just holding what I have

Watching from the sidelines

SELLAS Life Sciences ($SLS) is down over 10% today and well off its 52-week high of $15.88, as investors wait on final analysis of its Phase 3 REGAL trial in AML and Phase 2 data for SLS009 expected in the fourth quarter. Are you buying $SLS on the dip? Vote and explain your reasoning in the comments.

$SLS is down over 10% today but is still up over 125% year-to-date. Are you buying the dip?

Stocktwits

 is down over 10% today but is still up over 125% year-to-date. Are you buying the dip?

Current Price	$9.95
Prev Close	$11.34
Open	$11.20
Dividend Yield	0.00%
50-Day Moving Average	$12.45
Beta	0.96
Avg. Volume	6.39M
PE Ratio	-53.44

52-Week High	$15.88
52-Week Low	$1.39
Market Capitalization	$2.29B
EPS (Annual)	-$0.2463
Price to Book	16.63
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

SLS Fundamentals